Neuropeptide Y infusion into the shell region of the rat nucleus accumbens increases extracellular levels of dopamine

NeuroReport

Volumn 20, Issue 11, 2009, Pages 1023-1026

  Sørensen, Gunnar ^a,b   Wegener, Gregers ^c   Hasselstrøm, Jørgen ^c   Hansen, Thomas V O ^a   Wörtwein, Gitta ^a,b   Fink Jensen, Anders ^a,b   Woldbye, David P D ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Dopamine; Microdialysis; Neuropeptide Y; Nucleus accumbens shell; Reinforcement

Indexed keywords

DOPAMINE; NEUROPEPTIDE Y;

ADDICTION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; AREA UNDER CURVE; CATHETERIZATION; CHROMATOGRAPHY, LIQUID; DOPAMINE; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; NEUROPEPTIDE Y; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; TANDEM MASS SPECTROMETRY;

EID: 67749130801     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32832d4848     Document Type: Article

References (22)

1. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, et al. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 2004; 47:227-241. (Pubitemid 39298267)
2. Allen YS, Adrian TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, et al. Neuropeptide Y distribution in the rat brain. Science 1983; 221:877-879.
3. Massari VJ, Chan J, Chronwall BM, O'Donohue TL, Oertel WH, Pickel VM. Neuropeptide Y in the rat nucleus accumbens: ultrastructural localization in aspiny neurons receiving synaptic input from GABAergic terminals. J Neurosci Res 1988; 19:171-186. (Pubitemid 18090052)
4. Dumont Y, Fournier A, St-Pierre S, Quiron R. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J Neurosci 1993; 13:73-86. (Pubitemid 23028729)
5. Pickel VM, Beck-Sickinger AG, Chan J, Wieland HA. Y1 receptors in the nucleus accumbens: ultrastructural localization and association with neuropeptide Y. J Neurosci Res 1998; 52:54-68. (Pubitemid 28158825)
6. Wolak ML, de Joseph MR, Cator AD, Mokashi AS, Brownfield MS, Urban JH. Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry. J Comp Neurol 2003; 464:285-311. (Pubitemid 36992215)
7. Wahlestedt C, Karoum F, Jaskiw G,Wyatt RJ, Larhammer D, Ekman R, et al. Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex. Proc Natl Acad Sci U S A 1991; 88:2078-2082. (Pubitemid 21916357)
8. Olling JD, Ulrichsen J, Haugbøl S, Glenthøj B, Hemmingsen R,Woldbye DP. Decreased gene expression of neuropeptide Y and its receptors in hippocampal regions during ethanol withdrawal in rats. Neurosci Lett 2007; 424:160-164. (Pubitemid 47404751)
9. Thiele TE, Marsh DJ, Ste Marie L, Bernstein IL, Palmiter RD. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 1998; 396:366-369.
10. Woldbye DPD, Klemp K, Madsen TM. Neuropeptide Y attenuates naloxoneprecipitated morphine withdrawal via Y5-like receptors. J Pharmacol Exp Ther 1998; 284:633-636. (Pubitemid 28086652)
11. Woldbye DPD, Ulrichsen J, Haugbøl S, Bolwig TG. Ethanol withdrawal in rats is attenuated by intracerebroventricular administration of neuropeptide Y. Alcohol Alcohol 2002; 37:318-321. (Pubitemid 34830907)
12. Josselyn SA, Beninger RJ. Neuropeptide Y: intraaccumbens injections produce a place preference that is blocked by cis-flupenthixol. Pharmacol Biochem Behav 1993; 46:543-552.
13. Heilig M, Vècséi L, Wahlestedt C, Alling C, Widerlöv E. Effects of centrally administered neuropeptide Y (NPY) and NPY13-36 on the brain monoaminergic systems of the rat. J Neural Transm 1990; 79:193-208.
14. Kerkerian-Le Goff L, Forni C, Samuel D, Bloc A, Dusticier N, Nieoullon A. Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striatum. Brain Res Bull 1992; 28:187-193.
15. Ault DT, Radeff JM,Werling LL. Modulation of [3H]dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor. J Pharmacol Exp Ther 1998; 284:553-560. (Pubitemid 28086641)
16. Adewale AS, Macarthur H, Westfall TC. Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors. Neuropharmacology 2007; 52:1396-1402. (Pubitemid 46601532)
17. Wegener G, Volke V, Rosenberg R. Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br J Pharmacol 2000; 130:575-580. (Pubitemid 30332975)
18. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th ed. New York: Academic Press; 2006.
19. Hasselstrøm J, Linnet K. In vitro studies on quetiapine metabolism using substrate depletion approach with focus on drug-drug interactions. Drug Metabol Drug Interact 2006; 21:187-211.
20. Matos FF, Guss V, Korpinen C. Effects of neuropeptide Y (NPY) and [D-Trp32]NPY on monoamine and metabolite levels in dialysates from rat hypothalamus during feeding behavior. Neuropeptides 1996; 30: 391-398.
21. Meurs A, Clinckers R, Ebinger G, Michotte Y, Smolders I. Sigma 1 receptormediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y. Eur J Neurosci 2007; 26:3079-3092. (Pubitemid 350135171)
22. Kendrick KM. Microdialysis measurement of in vivo neuropeptide release. J Neurosci Methods 1990; 34:35-46.